Evidence map›Paper›PMID 36964880›Full record

ReviewEndocrine2023

The 5

Fulvio Basolo, Elisabetta Macerola, Anello Marcello Poma, Liborio Torregrossa

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Endocrine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Prognostic significance of the extent of extranodal extension in patients with pN1b papillary thyroid carcinoma: a retrospective cohort study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fulvio BasoloDepartment of Surgical, Medical, Molecular Pathology and Critical Area - University of Pisa, via Savi 10, Pisa, 56126, Italy. fulvio.basolo@unipi.it.ORCID 0000-0003-1657-5020
Elisabetta MacerolaDepartment of Surgical, Medical, Molecular Pathology and Critical Area - University of Pisa, via Savi 10, Pisa, 56126, Italy.
Anello Marcello PomaDepartment of Surgical, Medical, Molecular Pathology and Critical Area - University of Pisa, via Savi 10, Pisa, 56126, Italy.
Liborio TorregrossaDepartment of Surgical, Medical, Molecular Pathology and Critical Area - University of Pisa, via Savi 10, Pisa, 56126, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 5

Indexed as

Adenocarcinoma, FollicularEndocrine GlandsThyroid NeoplasmsHumansPrognosisWorld Health OrganizationDiagnostic pathologyEndocrine pathologyFollicular-derived thyroid cancerWHO classification system

Identifiers

PMID36964880
PMCPMC10199828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.